Women's Imaging

Radiologists who interpret traditional two-dimensional (2D) mammograms required little time in transitioning to reading digital breast tomosynthesis (DBT) exams or three-dimensional (3D) mammograms, and improved their accuracy in cancer detection, according to research published online Feb. 26 in Radiology.  

“There is no valid scientific data to show that thermographic devices, when used on their own or with another diagnostic test, are an effective screening tool for any medical condition, including the early detection of breast cancer or other diseases and conditions,” the FDA wrote. “The agency stresses that mammography is the only screening method proven to reduce deaths from breast cancer through early detection.”  

“These suggestions can help clinics and providers make changes to how they communicate screening mammogram results,” wrote Biren A. Shah, MD, of Virginia Commonwealth University Health System in Richmond, in a recent Journal of the American College of Radiology study.

For AI to become clinically feasible in women’s imaging, it must excel in the areas of performance, time, workflow and cost, according to an opinion piece published online in the American Journal of Roentgenology.  

Breast cancer screening centers may want to consider implementing digital breast tomosynthesis (DBT) and digital mammography (DM) into their practice, according to results of a recent Radiology study. Pairing both modalities significantly increased the sensitivity and specificity of detecting breast cancers.

The new American Society of Breast Surgeons' recommendations are based on a comprehensive review of the most impactful evidence in modern literature, data and national guidelines.

 

 

“Attempts to reduce this variation through clear guidelines and standardization may avoid confusion among referring physicians and patients, improve allocation of limited imaging resources, and reduce inconvenience to patients," wrote lead author Bhavika K. Patel, MD, of the Mayo Clinic in Phoenix, and colleagues in a recent study published in the Journal of the American College of Radiology. 

“Because breast parenchyma may reflect the biologic risk factors associated with breast cancer development, yielding the stromal parenchyma as an indicator of precancer, the combination of parenchyma and tumor characteristics may provide a stronger predictive model of malignancy,” lead author Hui Li, PhD, and colleagues wrote in a new study published in Radiology

Since 1989, the combination of mammography and improved breast cancer treatment has averted hundreds of thousands of breast cancer mortalities for U.S. women, according to new research published online Feb. 11 in the journal Cancer.

Despite the best current recommendations advocating women avoid mammograms before elective breast surgery, a large number of women still undergo pre-surgical screening, reported authors of a study published in JAMA Surgery. The unnecessary imaging may drive up healthcare costs and lead to unneeded tests.

Previously established frameworks for creating breast cancer screening bundled payment models are achievable, according to a new study published in the Journal of the American College of Radiology. The approaches could also incorporate the rise of digital breast tomosynthesis (DBT).

Implementing three-dimensional (3D) digital breast tomosynthesis (DBT) with standard digital mammography (DM) can reduce the number of patients committed to short-term follow-up screening, according to research published online Jan. 19 in Academic Radiology.